Clinical Safety and Standardization of PRP in Orthopedic Practice

The success of PRP therapy in orthopedics relies on safety, consistency, and clinical standardization. Autologous PRP minimizes immunological risks while delivering targeted regenerative benefits.

CE Marked Class IIb PRP systems ensure compliance with international medical device regulations, sterility requirements, and validated performance. Platelet concentrations exceeding 4 million provide sufficient biological potency for orthopedic regeneration.

From an academic standpoint, standardized PRP preparation is essential for evidence-based practice, clinical research, and long-term patient outcomes.

PRP in orthopedics is not an experimental approach — it is an established regenerative therapy supported by science and regulation.